Fox CB - Search Results

1

Optimizing a Multi-Component Intranasal Entamoeba Histolytica Vaccine Formulation Using a Design of Experiments Strategy.

Abhyankar MM, Orr MT, Kinsey R, Sivananthan S, Nafziger AJ, Oakland DN, Young MK, Farr L, Uddin MJ, Leslie JL, Burgess SL, Liang H, De Lima I, Larson E, Guderian JA, Lin S, Kahn A, Ghosh P, Reed S, Tomai MA, Pedersen K, Petri WA Jr, Fox CB. Abhyankar MM, et al. Among authors: fox cb. Front Immunol. 2021 Jun 25;12:683157. doi: 10.3389/fimmu.2021.683157. eCollection 2021. Front Immunol. 2021. PMID: 34248966 Free PMC article.

2

Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsions.

Fox CB, Lin S, Sivananthan SJ, Dutill TS, Forseth KT, Reed SG, Vedvick TS. Fox CB, et al. Pharm Dev Technol. 2011 Oct;16(5):511-9. doi: 10.3109/10837450.2010.495397. Epub 2010 Jun 16. Pharm Dev Technol. 2011. PMID: 20550484

3

Adjuvants for Leishmania vaccines: from models to clinical application.

Raman VS, Duthie MS, Fox CB, Matlashewski G, Reed SG. Raman VS, et al. Among authors: fox cb. Front Immunol. 2012 Jun 11;3:144. doi: 10.3389/fimmu.2012.00144. eCollection 2012. Front Immunol. 2012. PMID: 22701453 Free PMC article.

4

Effects on immunogenicity by formulations of emulsion-based adjuvants for malaria vaccines.

Fox CB, Baldwin SL, Vedvick TS, Angov E, Reed SG. Fox CB, et al. Clin Vaccine Immunol. 2012 Oct;19(10):1633-40. doi: 10.1128/CVI.00235-12. Epub 2012 Aug 15. Clin Vaccine Immunol. 2012. PMID: 22896687 Free PMC article.

5

Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy.

Fox CB, Barnes V L, Evers T, Chesko JD, Vedvick TS, Coler RN, Reed SG, Baldwin SL. Fox CB, et al. Influenza Other Respir Viruses. 2013 Sep;7(5):815-26. doi: 10.1111/irv.12031. Epub 2012 Nov 5. Influenza Other Respir Viruses. 2013. PMID: 23122325 Free PMC article.

6

Modern Vaccines/Adjuvants Formulation Session 6: Vaccine &Adjuvant Formulation & Production 15-17 May 2013, Lausanne, Switzerland.

Fox CB. Fox CB. Hum Vaccin Immunother. 2013 Sep;9(9):2007-8. doi: 10.4161/hv.25340. Epub 2013 Jun 20. Hum Vaccin Immunother. 2013. PMID: 23787558 Free PMC article.

7

Charged aerosol detection to characterize components of dispersed-phase formulations.

Fox CB, Sivananthan SJ, Mikasa TJ, Lin S, Parker SC. Fox CB, et al. Adv Colloid Interface Sci. 2013 Nov;199-200:59-65. doi: 10.1016/j.cis.2013.06.004. Epub 2013 Jun 18. Adv Colloid Interface Sci. 2013. PMID: 23855968 Review.

8

Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis.

Orr MT, Fox CB, Baldwin SL, Sivananthan SJ, Lucas E, Lin S, Phan T, Moon JJ, Vedvick TS, Reed SG, Coler RN. Orr MT, et al. Among authors: fox cb. J Control Release. 2013 Nov 28;172(1):190-200. doi: 10.1016/j.jconrel.2013.07.030. Epub 2013 Aug 9. J Control Release. 2013. PMID: 23933525 Free PMC article.

9

In vitro evaluation of TLR4 agonist activity: formulation effects.

Misquith A, Fung HW, Dowling QM, Guderian JA, Vedvick TS, Fox CB. Misquith A, et al. Among authors: fox cb. Colloids Surf B Biointerfaces. 2014 Jan 1;113:312-9. doi: 10.1016/j.colsurfb.2013.09.006. Epub 2013 Sep 19. Colloids Surf B Biointerfaces. 2014. PMID: 24121074 Free PMC article.

10

Key roles of adjuvants in modern vaccines.

Reed SG, Orr MT, Fox CB. Reed SG, et al. Among authors: fox cb. Nat Med. 2013 Dec;19(12):1597-608. doi: 10.1038/nm.3409. Epub 2013 Dec 5. Nat Med. 2013. PMID: 24309663 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

153 results

Search Page